Concepedia

Steven Snapinn

SS

76

Publications

14.7K

Citations

36

H-Index

1984

Active since

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Amgen (United States)

Sahlgrenska University Hospital

University of Michigan

Steven Snapinn is an author at United States Military Academy specializing in medicine, cardiovascular disease, and public health.

ORCID

Top concepts

Publications per year

1984–2022

76

Publications

76

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.4K citations · Full text

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Lars Lindholm, Hans Ibsen, Björn Dahlöf et al. · The Lancet · 2002 · 1.6K citations

, , +9

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study

William F. Keane, Barry M. Brenner, Dick de Zeeuw et al. · Kidney International · 2003 · 542 citations

, , +13

Withdrawal of Statins Increases Event Rates in Patients With Acute Coronary Syndromes

Christopher Heeschen, Christian W. Hamm, Ulrich Laufs et al. · Circulation · 2002 · 483 citations

Effects of Losartan on Cardiovascular Morbidity and Mortality in Patients With Isolated Systolic Hypertension and Left Ventricular Hypertrophy

Sverre E. Kjeldsen, Björn Dahlöf, Richard B. Devereux et al. · JAMA · 2002 · 442 citations

Rows per page

1–5 of 76